ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

How precision medicine, immunotherapy are influencing clinical trial design for cancer drugs – MedCity News

MedCity NewsHow precision medicine, immunotherapy are influencing clinical trial design for cancer drugsMedCity NewsNewfound understanding of the biology of cancer has spurred a wave of oncology drug approvals, creating previously unheard of treatment … Continue reading

2017-08-02 Michael Zand NEWS

Expert highlights CRISPR’s applications, limitations, and ethical … – News-Medical.net

Continue reading

2017-08-02 Michael Zand NEWS

Expert highlights CRISPR’s applications, limitations, and ethical concerns – News-Medical.net


The Scientist

Expert highlights CRISPR’s applications, limitations, and ethical …
News-Medical.net
“Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the …
Scientists Destroy Entire Chromosome with CRISPR | The Scientist …The Scientist
Gene Editing Is Revolutionizing Medicine but Causing a …Newsweek
UC Berkeley to host conference on gene-editing technology …Xinhua
satPRnews (press release)
all 5 news articles »
Continue reading

2017-08-02 Michael Zand NEWS

CRISPR – A spotlight on gene therapy and its potential role in personalized medicine – DOTmed.com

Expert highlights CRISPR’s applications, limitations, and ethical concerns
News-Medical.net
“Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely …

Continue reading

2017-08-01 Michael Zand NEWS

Stem cell trial shows promising results for children with autism – CityNews

CityNewsStem cell trial shows promising results for children with autismCityNewsAn innovative stem cell trial taking place at Duke University in North Carolina is giving hope to parents of children with autism, including one young Toronto family. Noah … Continue reading

2017-08-01 Michael Zand NEWS

Stem cell trial shows promising results for children with autism – CityNews

CityNewsStem cell trial shows promising results for children with autismCityNewsAn innovative stem cell trial taking place at Duke University in North Carolina is giving hope to parents of children with autism, including one young Toronto family. Noah … Continue reading

2017-08-01 Michael Zand NEWS

Stem cell trial shows promising results for children with autism – 680 News

680 NewsStem cell trial shows promising results for children with autism680 NewsAn innovative stem cell trial taking place at Duke University in North Carolina is giving hope to parents of children with autism, including one young Toronto family. Noah … Continue reading

2017-08-01 Michael Zand NEWS

Chiesi hands back gene therapy to uniQure – BioPharma Dive


DOTmed.com

CRISPR – A spotlight on gene therapy and its potential role in personalized medicine
DOTmed.com
AACC invited Jennifer Doudna, professor of molecular and cellular biology at UC Berkley, to deliver the keynote speech, in which she addressed her work in CRISPR-mediated genome editing. Doudna has been featured in many scientific journals as well as …
YFV Protein, Middle East Markets, Gene Editing and “Data Lakes” are among Developments at First Day of AACC 2017 …Markets Insider

all 4 news articles »

Continue reading

2017-08-01 Michael Zand NEWS
  • 1
  • …
  • 1,415
  • 1,416
  • 1,417
  • 1,418
  • 1,419
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

FierceBiotech

Chiesi hands back gene therapy to uniQure
BioPharma Dive
Just months after uniQure N.V. announced it would not renew the market authorization for gene therapy Glybera in Europe, the company confirmed its partner Chiesi Farmaceutici is pulling out of another gene therapy agreement. The companies said Monday …
Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy CandidateGenetic Engineering & Biotechnology News
Uniqure from now on aloneEuropean Biotechnology

all 5 news articles »